{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:56:36Z","timestamp":1778162196642,"version":"3.51.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,27]]},"abstract":"<jats:p>To investigate the causal relationship between metformin use and osteoporosis and different subtypes of osteoporosis using a 2-sample Mendelian randomization method. Data from genome-wide association studies were analyzed, with the exposure factor being metformin and the outcome variables being osteoporosis and different subtypes. Mendelian randomization was performed using Inverse Variance Weighted (IVW), MR-Egger, and weight median (WM) methods, and heterogeneity tests, horizontal multivariate analyses, and sensitivity analyses were performed. The IVW method analysis with metformin and osteoporosis showed <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20051.53E-04, OR (95%CI)\u2005=\u20051.81E-02 (2.27E-02-1.44E-01); the IVW method analysis with metformin and postmenopausal osteoporosis with pathologic fracture showed <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20052.22E-01, OR (95%CI)\u2005=\u20054.89E-02 (3. 83E-04-6.23E\u2005+\u200500); the IVW method using metformin with osteoporosis with pathological fracture showed that <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20052.14E-01, OR (95%CI)\u2005=\u20051.64E\u2005+\u200500(5.78E-02-6.44E-04); the IVW method using metformin with pharmacological osteoporosis with pathological fracture showed that <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20059. 83E- 01, OR (95%CI)\u2005=\u20051.11E\u2005+\u200500 (3.99E-05-3.11E\u2005+\u200504); IVW method of metformin use and pharmacological osteoporosis showed that <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20055.99E-01, OR (95%CI)\u2005=\u20052.27E\u2005+\u200501 (2.00E-04-2.57E\u2005+\u200506); there is a causal relationship between metformin use and osteoporosis, but there is no causal relationship between metformin use and postmenopausal osteoporosis with pathological fracture, osteoporosis with pathological fracture, pharmacological osteoporosis, and pharmacological osteoporosis with pathological fracture, and metformin use is a protective factor for osteoporosis.<\/jats:p>","DOI":"10.1097\/md.0000000000035191","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T23:03:50Z","timestamp":1707519830000},"page":"e35191","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Causal association of metformin and osteoporosis: A 2-sample Mendelian randomization study"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3158-8991","authenticated-orcid":false,"given":"Yong-Kang","family":"Wei","sequence":"first","affiliation":[{"name":"The Fourth Clinical Medical College of Xinjiang Medical University, Urumqi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Bo","family":"Chen","sequence":"additional","affiliation":[{"name":"Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Urumqi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Ling","family":"Ju","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Hua","family":"Deng","sequence":"additional","affiliation":[{"name":"Ya\u2019an City Hospital of Traditional Chinese Medicine, Ya\u2019an, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis.","volume":"2","author":"Eastell","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00198-023-06720-y","article-title":"Epidemiology of male osteoporosis in Denmark (1996-2018).","volume":"34","author":"Bruhn","year":"2023","journal-title":"Osteoporos Int"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis.","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges.","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7326\/M15-1361","article-title":"Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American college of physicians.","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2337\/diacare.23.4.564","article-title":"Link between diabetes and osteoporosis.","volume":"23","author":"Basaria","year":"2000","journal-title":"Diabetes Care"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.metabol.2014.09.002","article-title":"Type 2 diabetes mellitus and fracture risk.","volume":"63","author":"Dede","year":"2014","journal-title":"Metabolism"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jdiacomp.2011.02.004","article-title":"Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications.","volume":"25","author":"Vi\u00e9gas","year":"2011","journal-title":"J Diabetes Complications"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.biopha.2018.11.032","article-title":"Metformin; an old antidiabetic drug with new potentials in bone disorders.","volume":"109","author":"Bahrambeigi","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00774-019-00989-y","article-title":"Preventative effects of metformin on glucocorticoid-induced osteoporosis in rats.","volume":"37","author":"Zhao","year":"2019","journal-title":"J Bone Miner Metab"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"944323","DOI":"10.3389\/fendo.2022.944323","article-title":"Linagliptin in combination with metformin ameliorates diabetic osteoporosis through modulating BMP-2 and Sclerostin in the High-Fat Diet Fed C57BL\/6 Mice.","volume":"13","author":"Nirwan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R12-20250504","first-page":"a041302","article-title":"Mendelian randomization.","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"918749","DOI":"10.3389\/fimmu.2022.918749","article-title":"Causal relationship between sleep traits and risk of systemic lupus erythematosus: a two-sample mendelian randomization study.","volume":"13","author":"Sang","year":"2022","journal-title":"Front Immunol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12863-022-01082-6","article-title":"Pulmonary embolism and 529 human blood metabolites: genetic correlation and two-sample Mendelian randomization study.","volume":"23","author":"Feng","year":"2022","journal-title":"BMC Genom Data"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"g6284","DOI":"10.1136\/bmj.g6284","article-title":"Multiple hypothesis testing and Bonferroni\u2019s correction.","volume":"349","author":"Sedgwick","year":"2014","journal-title":"BMJ"},{"key":"R16-20250504","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84051","article-title":"Smoking, alcohol consumption, and 24 gastrointestinal diseases: Mendelian randomization analysis.","volume":"12","author":"Yuan","year":"2023","journal-title":"Elife"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"9160","DOI":"10.1002\/cam4.3493","article-title":"Depression and prostate cancer risk: a Mendelian randomization study.","volume":"9","author":"Chen","year":"2020","journal-title":"Cancer Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11144193","article-title":"Effects of metformin on bone mineral density and adiposity-associated pathways in animal models with type 2 diabetes mellitus: a systematic review.","volume":"11","author":"Loh","year":"2022","journal-title":"J Clin Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"101350","DOI":"10.1016\/j.diabet.2022.101350","article-title":"Metformin treatment is associated with an increase in bone mineral density in type 2 diabetes mellitus patients in China: a retrospective single center study.","volume":"48","author":"Sun","year":"2022","journal-title":"Diabetes Metab"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.3390\/jcm9092839","article-title":"Metformin attenuates osteoporosis in diabetic patients with carcinoma in situ: a nationwide, retrospective, matched-cohort study in Taiwan.","volume":"9","author":"Lu","year":"2020","journal-title":"J Clin Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2008.08.034","article-title":"Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.","volume":"375","author":"Kanazawa","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1089\/scd.2021.0181","article-title":"Metformin rescues the impaired osteogenesis differentiation ability of rat adipose-derived stem cells in high glucose by activating autophagy.","volume":"30","author":"Zhang","year":"2021","journal-title":"Stem Cells Dev"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"113120","DOI":"10.1016\/j.yexcr.2022.113120","article-title":"Metformin alleviates dexamethasone-induced apoptosis by regulating autophagy via AMPK\/mTOR\/p70S6K in osteoblasts.","volume":"415","author":"Guo","year":"2022","journal-title":"Exp Cell Res"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12964-022-00966-5","article-title":"Metformin alleviates bone loss in ovariectomized mice through inhibition of autophagy of osteoclast precursors mediated by E2F1.","volume":"20","author":"Xie","year":"2022","journal-title":"Cell Commun Signal"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3892\/ijmm.2023.5239","article-title":"Metformin reverses oxidative stress-induced mitochondrial dysfunction in pre-osteoblasts via the EGFR\/GSK-3\u03b2\/calcium pathway.","volume":"51","author":"Cao","year":"2023","journal-title":"Int J Mol Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"121092","DOI":"10.1016\/j.lfs.2022.121092","article-title":"Metformin suppresses oxidative stress induced by high glucose via activation of the Nrf2\/HO-1 signaling pathway in type 2 diabetic osteoporosis.","volume":"312","author":"Chen","year":"2023","journal-title":"Life Sci"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"e1970","DOI":"10.1097\/MJT.0000000000000292","article-title":"DRESS syndrome following metformin administration: a case report and review of the literature.","volume":"23","author":"Voore","year":"2016","journal-title":"Am J Ther"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3389\/fphys.2018.00775","article-title":"Understanding the representative gut microbiota dysbiosis in metformin-treated type 2 diabetes patients using genome-scale metabolic modeling.","volume":"9","author":"Rosario","year":"2018","journal-title":"Front Physiol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40264-020-00913-8","article-title":"Sex differences in adverse drug reactions of metformin: a longitudinal survey study.","volume":"43","author":"de Vries","year":"2020","journal-title":"Drug Saf"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:09:13Z","timestamp":1746328153000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":30,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035191","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]}}}